The honorable profession we now call veterinary medicine has effectively been in existence since humans first began the practice of animal husbandry for survival and productivity purposes. There are jokes about the worlds oldest and second oldest professions, but in reality, veterinary medicine probably has both of them beat.
Historians and archaeologists have found Chinese writings concerning the diseases of horses, oxen, and buffalo dated as early as 2,500 B.C. Four thousand year old Indian art depictions illustrate men caring for horses and elephants, and ancient Egyptian art illustrate methods of caring for cattle and dogs as well.
Multiple IV Fluid products recalled
On July 14, 2014, Baxter Initiates Voluntary Worldwide Recall Of Four Lots Of IV Solutions Due To The Presence Of Particulate Matter.
Baxter International Inc. announced today it is voluntarily recalling four lots of intravenous (IV) solutions to the hospital/user level. These products have been found to contain particulate matter identified as cellulosic fibers and/or plastics.
Tramadol becomes Controlled Substance in August, 2014
On July 2, 2014, the DEA published in the Federal Register the final rule placing tramadol into schedule IV of the Controlled Substances Act. This rule will become effective on August 18, 2014. All regulatory requirements applicable to schedule IV controlled substances will apply to tramadol beginning August 18, 2014. The final rule is available online at www.regulations.gov.
Looks like Dr. Becker had enough of being made a fool of by sensationalist media types. We should all learn from his mistakes.
Longtime Good Morning America contributor makes decision after 20/20 report critical of veterinarians.
Nov 27, 2013
By: Julie Scheidegger
A regular guest on Good Morning America and several other television shows, Marty Becker, DVM, told dvm360 today that he is ending his longtime relationship with ABC. This comes after Becker says producers of 20/20 misled him regarding an interview he gave for the show's Nov. 22 segment, "Is Your Veterinarian Being Honest with You?" which suggested that practitioners push unnecessary vaccinations and procedures to build their bottom line.
"I will no longer work with the ABC network effective Nov. 27," Becker says in his statement. "I've enjoyed the 17 years we worked together and made many lifelong friends along the way. I deeply appreciate all of the opportunities I had on Good Morning America to promote the things I love: pets, pet owners and my beloved profession. However, for a number of reasons, I have made the decision that it's time I move on."
We'll be learning more about Apoquel in our CE meeting on December 15th!
Zoetis, Inc. (NYSE: ZTS), formerly the animal health business unit of Pfizer Inc., today announced that the U.S. Food and Drug Administration (FDA) has approved APOQUEL® (oclacitinib tablet) for the control of pruritus associated with allergic dermatitis and the control of atopic dermatitis in dogs at least 12 months of age. Pruritus, or itching, is the most common sign of allergies in dogs. Developed by Zoetis, APOQUEL is the first Janus kinase (JAK) inhibitor approved for veterinary use that targets the itch and inflammation pathway. APOQUEL provides fast-acting relief from itching and improves inflammation for the estimated 8.2 million dogs that suffer from short- and long-term allergic skin conditions.
"Previously available treatments have helped with the management of allergic skin disease in dogs, but an unmet need still exists for a treatment that works rapidly and effectively with minimal short- and long-term side effects," said Douglas DeBoer, DVM, DACVD, Professor of Dermatology at the University of Wisconsin-Madison School of Veterinary Medicine, an expert in veterinary dermatology and allergy. "The approval of APOQUEL is encouraging because it will provide both veterinarians and pet owners with a treatment that reduces itch within hours and provides long term relief of itching and inflammation for dogs without the side effects of steroids."